PYC Therapeutics Director Bolsters Shareholding
Company Announcements

PYC Therapeutics Director Bolsters Shareholding

PYC Therapeutics Limited (AU:PYC) has released an update.

Alan William Tribe, a director of PYC Therapeutics Limited, acquired 50 million ordinary shares in an off-market transaction valued at $5,250,000, increasing his indirect holdings to 1,587,267,467 shares. The significant financial move, reported to the ASX in compliance with listing rules, reflects a noteworthy change in the director’s interest in the company.

For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!